Vitamin d3 mimics
CA 2339775 A1 · Owner: Boehm, Marcus F. · Inventors: Allegretto, Elizabeth A.; Boehm, Marcus F.; Nadzan, Alex M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates to non-secosteroidal compounds which activate and modulate the vitamin D receptor (VDR). Because the compounds of the present invention display many of the beneficial properties of 1,25(OH)2D3 but with reduced calcium mobilization effects they may be used advantageously , to treat and prevent conditions that show vitamin D sensitivity. Such disease states typically show abnormal calcium regulatory abnormal immune responsive, hyperproliferative and/or neurodegenerative characteristics.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 12, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 12, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 12, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.